EXPLORING THE FUTURE OF MEDICINE: VITAL BIOBANK ORGANOID TECHNOLOGY

Our Technology

A complex cell culture model formed from tissue samples, capable of self-organizing into a three-dimensional structure that best reflects in vitro the in vivo conditions of its original organ, preserving different cellular interactions and reproducing proliferative, metabolic, and drug exposure gradients.

Key Features of Vital Organoids

Derived from tissue samples

Physiological relevance

Genetic and phenotypic stability

High predictability of patient response

Scalability for large-scale screening

Suitable for genetic manipulation

High efficiency in establishment

Exploring Possibilities with Vital Organoid Technology

Welcome to a universe of scientific innovation and advancement that is reshaping the landscape of medical research. Our Vital Organoid Technology is at the forefront of cutting-edge solutions, empowering you to revolutionize patient-centered drug discovery and treatments.

Drug Development

Minimize drug attrition and anticipate patient response with our preclinical services and laboratory clinical trials. Take drug development to a closer clinical level.

Customized Solutions

Unravel the complexity of human diseases with our development of custom models and assays.

a laboratory lab with a microscope and a microscope
a laboratory lab with a microscope and a microscope

Thousands of Patient-Derived Organoids in Various Disease Indications

Our organoid models undergo rigorous quality control processes, ensuring the highest standards

a man in a lab coat and a medical device
a man in a lab coat and a medical device

Vital Organoids faithfully recreate the patient's pathobiology, providing superior preclinical models for compound testing and shortening the distance to clinical trials. Vital Organoids can support decision-making at every stage of the drug development pipeline, assisting in the development of transformative treatments for patients.

Reduce risks and navigate the drug development journey with confidence using patient-derived organoids.